
WB analysis of HeLa cell lysates using GTX86891 Plasma Kallikrein 1B (cleaved Arg390) antibody. The lane on the right is blocked with the synthesized peptide.
Plasma Kallikrein 1B (cleaved Arg390) antibody
GTX86891
Overview
- SupplierGeneTex
- Product NamePlasma Kallikrein 1B (cleaved Arg390) antibody
- Delivery Days Customer9
- Antibody SpecificityPlasma Kallikrein 1B (cleaved Arg390) antibody detects endogenous levels of fragment of activated KLKB1 resulting from cleavage adjacent to Arg390.
- Application Supplier NoteWB: 1:500~1:1000. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- FormulationLiquid
- Gene ID3818
- Target nameKLKB1
- Target descriptionkallikrein B1
- Target synonymskallikrein B, plasma (Fletcher factor) 1; kininogenin; KLK3; PKK; PKKD; plasma kallikrein; plasma prekallikrein; PPK
- Protein IDP03952
- Protein NamePlasma kallikrein
- Scientific DescriptionPlasma prekallikrein is a glycoprotein that participates in the surface-dependent activation of blood coagulation, fibrinolysis, kinin generation and inflammation. It is synthesized in the liver and secreted into the blood as a single polypeptide chain. Plasma prekallikrein is converted to plasma kallikrein by factor XIIa by the cleavage of an internal Arg-Ile bond. Plasma kallikrein therefore is composed of a heavy chain and a light chain held together by a disulphide bond. The heavy chain originates from the amino-terminal end of the zymogen and contains 4 tandem repeats of 90 or 91 amino acids. Each repeat harbors a novel structure called the apple domain. The heavy chain is required for the surface-dependent pro-coagulant activity of plasma kallikrein. The light chain contains the active site or catalytic domain of the enzyme and is homologous to the trypsin family of serine proteases. Plasma prekallikrein deficiency causes a prolonged activated partial thromboplastin time in patients. [provided by RefSeq, Jul 2008]
- Storage Instruction-20°C or -80°C,2°C to 8°C
- UNSPSC12352203